Homology Medicines
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Homology Medicines's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 307% to -$6,651,000. The net income dropped to -$53,743,000 and profit margin reached 808%. Total operating expenses were $9,875,000.

Profit Margin

Homology Medicines, Inc. (LSE:0T6G.L): Profit margin
2016 0 -8.04M
2017 0 -29.99M
2018 5.32M -55.57M -1044.29%
2019 1.66M -103.91M -6237.45%
2020 2.70M -128.69M -4762.92%
2021 33.97M -95.76M -281.9%
2022 3.20M -5.00M -156.02%
2023 -6.65M -53.74M 808.04%

0T6G.L Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
-6.65M3.20M33.97M2.70M1.66M5.32M00
Cost of revenue
578K2.59M9.54M100.39M89.39M47.94M684.21K0
Gross profit
-7.22M609K24.42M-97.69M-87.73M-42.62M-684.21K0
Operating exp.
Research and development
31.72M98.35M93.08M100.39M89.39M47.94M21.37M5.69M
Selling and marketing
0-2.59M-9.54M-8.90M-6.31M0-683.87K0
Total operating expenses
9.87M133.88M120.37M124.06M105.29M17.3M28.97M8.07M
Operating income
-48.25M-133.28M-95.94M-130.26M-109.94M-59.92M-29.65M-10.00M
Other income (expenses), net
-5.17M134.47M185K1.56M6.02M4.34M-333.36K1.95M
Income before tax
-53.42M1.19M-95.76M-128.69M-103.91M-55.57M-29.99M-8.04M
Income tax expense
318K715K547K-100-40
Net income
-53.74M-5.00M-95.76M-128.69M-103.91M-55.57M-29.99M-8.04M
Earnings per share
Basic EPS
-7.41-1.57-31.18-50.46-44.41-1.32-14.42-4.23
Diluted EPS
-7.41-1.57-31.18-50.46-44.41-1.32-14.42-4.23
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source